Core Viewpoint - Semler Scientific, Inc. is facing a class action lawsuit due to allegations of misleading statements and failure to disclose a significant investigation by the U.S. Department of Justice regarding potential violations of the False Claims Act [3][4]. Group 1: Class Action Details - The class action lawsuit represents investors who purchased Semler Scientific securities between March 10, 2021, and April 15, 2025 [1]. - Investors have until October 28, 2025, to file a lead plaintiff motion [1]. Group 2: Allegations and Investigations - The lawsuit claims that during the class period, the company made false statements and did not disclose a civil investigative demand from the DOJ regarding improper marketing of devices as reimbursable by Medicare [3][4]. - On February 28, 2025, Semler disclosed the DOJ's investigation, which led to a stock price drop of over 9% [4]. Group 3: Settlement and Financial Impact - On April 15, 2025, Semler announced a settlement agreement of $29.75 million to resolve all claims, resulting in a nearly 10% decline in the company's stock price [5].
Semler Scientific, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; October 28, 2025 Deadline to file Lead Plaintiff Motion